Zymed Laboratories develops tissue microarrays, cell biology reagents and other proteomics reagents.

History:

Zymed was acquired by Invitrogen in early 2005.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Northern California

Research Focus:
Instrumentation/Reagents Microarray/Chip Technologies Proteomics

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: